BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27301015)

  • 21. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
    Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States.
    Ahmad Y; Gertz RE; Li Z; Sakota V; Broyles LN; Van Beneden C; Facklam R; Shewmaker PL; Reingold A; Farley MM; Beall BW
    J Clin Microbiol; 2009 Jul; 47(7):2046-54. PubMed ID: 19386831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular subtyping and antimicrobial susceptibility of
    Oh SI; Kim JW; Kim J; So B; Kim B; Kim HY
    J Vet Sci; 2020 Jul; 21(4):e57. PubMed ID: 32735095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of virulence genes to clinical manifestations and outcome in patients with Streptococcus dysgalactiae subspecies equisimilis bacteremia.
    Tsai CT; Chi CY; Ho CM; Lin PC; Chou CH; Wang JH; Wang JH; Lin HC; Tien N; Lin KH; Ho MW; Lu JJ
    J Microbiol Immunol Infect; 2014 Dec; 47(6):462-8. PubMed ID: 24210866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multilocus sequence analysis of Streptococcus canis confirms the zoonotic origin of human infections and reveals genetic exchange with Streptococcus dysgalactiae subsp. equisimilis.
    Pinho MD; Matos SC; Pomba C; Lübke-Becker A; Wieler LH; Preziuso S; Melo-Cristino J; Ramirez M
    J Clin Microbiol; 2013 Apr; 51(4):1099-109. PubMed ID: 23345291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group a streptococcus antibiotic resistance in southern Brazil: a 17-year surveillance study.
    Torres RS; Torres RP; Smeesters PR; Palmeiro JK; de Messias-Reason IJ; Dalla-Costa LM
    Microb Drug Resist; 2011 Jun; 17(2):313-9. PubMed ID: 21417774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil.
    Souza VC; Kegele FC; Souza SR; Neves FP; de Paula GR; Barros RR
    Scand J Infect Dis; 2013 Oct; 45(10):780-5. PubMed ID: 23876189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
    Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
    J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly prevalent emmSTG840.0 and emmSTC839.0 types of erythromycin non-susceptible group G Streptococcus isolated from bacteremia in southern Taiwan.
    Zheng PX; Chan YC; Chiou CS; Hsieh CL; Chiang-Ni C; Wu JJ
    J Microbiol Immunol Infect; 2017 Dec; 50(6):831-838. PubMed ID: 28711431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness.
    Pinho MD; Melo-Cristino J; Ramirez M
    J Clin Microbiol; 2006 Mar; 44(3):841-6. PubMed ID: 16517864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina.
    Lopardo HA; Vidal P; Sparo M; Jeric P; Centron D; Facklam RR; Paganini H; Pagniez NG; Lovgren M; Beall B
    J Clin Microbiol; 2005 Feb; 43(2):802-7. PubMed ID: 15695683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Complement-Mediated Cell Lysis-like Gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis Isolates From Japan (2014-2016).
    Takahashi T; Fujita T; Shibayama A; Tsuyuki Y; Yoshida H
    Ann Lab Med; 2017 Jul; 37(4):297-304. PubMed ID: 28445008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China.
    Li H; Zhou L; Zhao Y; Ma L; Liu X; Hu J
    BMC Infect Dis; 2020 Jul; 20(1):507. PubMed ID: 32660436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
    Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. emm typing, antibiotic resistance and PFGE analysis of Streptococcus pyogenes in Lebanon.
    Bahnan W; Hashwa F; Araj G; Tokajian S
    J Med Microbiol; 2011 Jan; 60(Pt 1):98-101. PubMed ID: 20864546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro, Brazil.
    d'Oliveira RE; Barros RR; Mendonça CR; Teixeira LM; Castro AC
    Microb Drug Resist; 2003; 9(1):87-91. PubMed ID: 12705687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
    Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
    J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization and antibiotic resistance of group G streptococci in Israel: comparison of invasive, non-invasive and carriage isolates.
    Halperin T; Levine H; Korenman Z; Burstein S; Amber R; Sela T; Valinsky L
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1649-54. PubMed ID: 27325440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular epidemiology, antimicrobial susceptibility, and characterization of macrolide-resistant Streptococcus pyogenes in Japan.
    Tanaka Y; Gotoh K; Teramachi M; Ishimoto K; Tsumura N; Shindou S; Yamashita Y
    J Infect Chemother; 2016 Nov; 22(11):727-732. PubMed ID: 27645122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Emm typing by genetic identification of Streptococcus dysgalactiae subsp. equisimilis and susceptibility to oral antibiotics].
    Sunaoshi KS; Aburahashi H; Kobayashi R; Yamamoto Y; Okuzumi K; Yoshida A; Misawa Y; Adachi K; Ubukata K
    Kansenshogaku Zasshi; 2006 Sep; 80(5):488-95. PubMed ID: 17073261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.